"10.1371_journal.pone.0142190","plos one","2015-11-05T00:00:00Z","Johanna S√°pi; Levente Kov√°cs; D√°niel Andr√°s Drexler; P√°l Kocsis; D√°vid Gaj√°ri; Zolt√°n S√°pi","Research and Innovation Center of Obuda University, Physiological Controls Group, Obuda University, Budapest, Hungary; Department of Control Engineering and Information Technology, Budapest University of Technology and Economics, Budapest, Hungary; Preclinical Imaging Center, Gedeon Richter Plc., Budapest, Hungary; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary","Conceived and designed the experiments: ZS JS. Performed the experiments: JS ZS PK DG. Analyzed the data: JS ZS PK DG DAD LK. Contributed reagents/materials/analysis tools: ZS PK LK. Wrote the paper: JS ZS PK LK.","The authors have the following interests: Coauthors PK and DG are employed by Gedeon Richter Ltd. Avastin (bevacizumab) is manufactured by Genentech, Inc., South San Francisco, California, USA; EU patent expiry in 2019 in the US and 2022 in EU. There are no further patents, products in development or marketed products to declare. This does not alter the authors‚Äô adherence to all the PLOS ONE policies on sharing data and materials.","2015","11","Johanna S√°pi","JS√",6,TRUE,2,4,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
